About Us

About Us


The Open Health Systems Laboratory (OHSL) is a public benefit corporation that builds, supports and manages project teams to improve research and diagnosis outcomes. We have technical expertise in utilizing the latest developments in information technology, namely informatics, communication, natural language processing, and data collection and mining to bring solutions to our clients.

Our knowledge of the U.S. federal research grants and contracts process, and our extensive global network and access to top researchers throughout the world has helped deliver better access to health care services and has improved research outcomes to our customers.

We are attuned to international health systems policy and technology trends;

We encourage and incubate ideas for innovative problem solving in life sciences research through collaborations;


We install mechanisms for funding, program management, evaluation, execution, and entrepreneurship in the life sciences.

OHSL was originally created in 2008 as a program of the International Network for Cancer Treatment and Research (INCTR) , a not-for-profit organization dedicated to helping build capacity for cancer research and treatment. In 2011, OHSL incorporated as an independent non-profit organization, and re-incorporated in 2017 as a public benefit corporation (B-Corp).

OHSL is built upon the work of its founders with other leading research, education, and development institutions like Duke University, California State University, Moffitt Cancer Center, Ohio State University, Indiana University, Boston University, Stanford University, National Cancer Institute, Institute of Medicine, International Network for Cancer Treatment and Research, Public Health Foundation of India, Einstein School of Medicine/Yeshiva University, University of Maryland, Pune University, University of Calcutta, World Bank, and World Health Organization.

Click here to view a full list of our partners.

Our Strategy





  • Encouraging pre-competitive collaboration among scientists; mapping research resources worldwide; connecting collaborators leveraging the semantic web and increasing capability of social media and open source tools.
  • Mapping sources of funding and support of medical research worldwide and working with funding agencies and foundations to address the needs of global medical research.
  • Building and managing international consortia that will address provocative questions of medical science with a view to reduce the global burden of disease.
  • Creating a global knowledge cloud for medical research and treatment to support global health with a team science approach and using biomedical informatics, information technology and International Research Network Cooperation (IRNC) .
  • Promoting open source, interoperable, standards based software and providing inventory, integration, training, and support.
  • Building a global community of users for deployment and co-development of caBIG (cancer Biomedical Informatics Grid)
  • Creating a globally shared cyberinfrastructure for medical research including high performance computing (HPC) for life sciences with advanced network connection, in partnership with University Corporation for Advancement and Internet Development (UCAID/Internet2), and Mid-Atlantic Crossing (MAX).
  • Initiating a pre-competitive research consortium for in silico drug design and development from botanical and herbal molecules.
  • Supporting innovation in biomedical research including biospecimen, biomarkers and clinical trials, especially emerging models for Comprehensive Dynamic Trials, Adaptive Trials, and Virtual Trials.
  • Promoting information proficiency and meaningful use of human-centered, outcomes-oriented appropriate technology, where the ability to adopt and adapt resides with the user community.